Age and duration of biological DMARD use are the two significant factors associated with an increased risk of serious infections in RA patients, a WA registry study has shown. In a ten-year retrospective review of all RA patients treated with bDMARDs in WA, researchers identified 46 hospital admissions for serious infections that warranted antibiotic treatment. ...
WA study highlights 2 factors for serious infections with bDMARDs
By Michael Woodhead
25 Sep 2018